Axcelis ( (ACLS) ) has released its Q4 earnings. Here is a breakdown of the information Axcelis presented to its investors.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Axcelis Technologies, Inc., headquartered in Beverly, Massachusetts, is a prominent player in the semiconductor industry, providing cutting-edge ion implantation systems vital for integrated circuit manufacturing.
In its recent financial report, Axcelis Technologies announced its results for the fourth quarter and full year of 2024. The company recorded a quarterly revenue of $252.4 million with a diluted earnings per share of $1.54. Although full-year revenue saw a decline to $1.02 billion from $1.13 billion in 2023, the company managed to maintain profitability and improve gross margins.
Key performance metrics for the fourth quarter included an operating margin of 21.6% and a gross margin increase to 46.0%. The company’s full-year operating profit stood at $210.8 million, while net income was reported at $201 million, translating to $6.15 per diluted share. Despite a drop in revenue and net income compared to the previous year, Axcelis achieved a higher gross margin of 44.7%, up from 43.5% in 2023, showcasing improved financial efficiency.
Looking ahead, Axcelis anticipates a cyclical period in the semiconductor market as customers adjust to past investments, particularly in mature node capacity in China. The management remains optimistic about future growth, focusing on product innovation and cost management to strengthen its position for upcoming market opportunities. The company expects first-quarter 2025 revenues to be approximately $185 million with earnings per diluted share of $0.38.
